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Pregnancy and early life are characterized by marked changes in body microbial composition. 
Intriguingly, these changes take place simultaneously with neurodevelopmental plasticity, 
suggesting a complex dialogue between the microbes that inhabit the gastrointestinal tract and 
the brain. The purpose of this chapter is to describe the natural trajectory of microbiota during 
pregnancy and early life, as well as review the literature available on its interaction with 
neurodevelopment. Several lines of evidence show that the gut microbiota interacts with diet, 
drugs and stress both prenatally and postnatally. Clinical and preclinical studies are illuminating 
how these disruptions result in different developmental outcomes. Understanding the role of the 
microbiota in neurodevelopment may lead to novel approaches to the study of the 
pathophysiology and treatment of neuropsychiatric disorders.
Introduction 
The connection between the brain and the gastrointestinal tract has been extensively 
studied, but the existence of a bidirectional microbiota-gut-brain axis has only received attention 
in the last decade [1, 2]. The individual microorganisms that live in our body, the microbiota, and 
their collective genomes, the microbiome, exert considerable influence over host brain and 
behaviour [3, 4]. (Table 1). Variations in microbiota composition have been linked to 
neuropsychiatric disorders, including autism, stress, anxiety and major depressive disorder [3, 
5].  
Almost 30 years ago, it was proposed that prenatal and postnatal environmental factors 
interact with genetics to program health and disease in adulthood [6, 7]. Building on Barker’s 
hypothesis, it was recently proposed that the microbiota could play an important role in 
programming adult brain health and disease [8]. Whether diet or other factors, such as stress 
and drugs, interact with the microbiota in early life to program brain health is currently being 
addressed by clinical and preclinical studies. This chapter reviews the natural trajectory of the 
composition of the microbiota during pregnancy and early life and outlines the current 
knowledge on the interaction between the microbiota and neurodevelopment.  
Early-Life Neurodevelopmental Plasticity and the Microbiota 
Dramatic structural and functional changes in the brain are characteristic of the first years 
of life. This neurodevelopmental plasticity requires timely and adequate migration, division and 
differentiation of neuronal and glial precursors [9]. Neuronal migration and axonal guidance 
establish short- and long-range connections that enable the recruitment of multiple brain areas 
for the execution of complex behaviours [10, 11]. Differentiated oligodendrocytes insulate 
neuronal axons with a myelin sheath to guarantee proper conductance of neuronal signals [12]. 
A growing emphasis is now placed on the role of astrocytes and microglia in facilitating synaptic 
pruning during early life through adolescence, allowing later in life the fine tuning of complex 
circuits [13]. Plasticity is a key feature of the standard neurodevelopmental trajectory and 
modulates the dynamics of synaptic connections and neural circuitry formation. Deviations from 
the neurodevelopmental trajectory can account for increased susceptibility to brain diseases 
later in life. 
There is a growing appreciation of the link between neurodevelopment and intestinal 
microbiota. Studies in germ-free mice have shown abnormal brain development, especially in 
male mice [14–16]. More recent studies in these microbiota-deficient mice have shown altered 
expression of genes implicated in neurophysiology processes, such as neurotransmission, 
neuronal plasticity, metabolism and morphology in the amygdala [17] and hippocampus [18]. 
Hypermyelination in the prefrontal cortex and abnormal microglia maturation characterize the 
glia profile of these animals [19–23]. Furthermore, they showed increased blood-brain barrier 
permeability [24]. Functionally, such changes translate to increased stress response [14, 16], 
changes in anxiety [25] and fear recall [26], cognitive deficits [27], social changes [21, 28] and 
visceral pain responses [29]. Thus, the complete absence of microbial colonization in early life 
has dramatic effects on offspring’s brain development and function (Table 1). 
Dynamics of the Maternal Microbiota during Pregnancy 
Pregnancy is a unique period in human life, and both the gut and vaginal microbiome 
have evolved to follow an optimum trajectory to support the mother and the developing fetus 
and allow for the ideal handover of microbiome at birth, informing maternal and child health 
outcomes.  
The human female gut microbiota undergoes dynamic compositional changes across 
gestation [30–32]. As pregnancy progresses, a reduction in the diversity of the intestinal 
microbiota takes place, characterized by an enrichment in Proteobacteria [30]. This natural shift 
in the bacterial populations is functional to the increased metabolic demands by the developing 
fetus. The Proteobacteria expansion can help the body with the increased energetic 
requirement that is characteristic of the third trimester [33]. Interestingly, when gut microbiota 
from this time period was transferred to microbiota-depleted rats, they showed increased 
adiposity, reduced glucose tolerance and inflammation, signs of metabolic syndrome [30]. This 
suggests that the changes in gut microbiota composition during pregnancy have an adaptive 
role for maternal and newborn health.  
The vaginal microbiota composition also changes during pregnancy towards a less 
diverse configuration [34, 35]. As with gastrointestinal microbiota, the change in vaginal 
microbiota has a specific role during pregnancy. An increase in the presence of Lactobacilli 
helps maintain a low pH, limiting bacterial growth opportunity for other bacteria [35]. 
Furthermore, vaginal microbiota composition is critical in the context of vertical transmission of 
microbial populations [36]. Whether interventions in the physiological trajectory of maternal 
microbiota could alter the prenatal environment and, in turn, deviate normal brain development 
is a key question in neuroscience that is starting to be addressed both in preclinical and clinical 
areas (Fig. 1). 
Preclinical Models of Early-Life Microbiota Trajectory 
Similar to humans, mice and rat intestinal and vaginal microbiota go through 
compositional changes during pregnancy, providing a robust preclinical model for studying the 
link between maternal gut environment and offspring brain development [37–40]. Early 
gestation is characterized by a transitional increase in the relative abundance of Akkermansia 
and Bifidobacterium, which in late pregnancy decrease to levels seen in non-pregnant mice. In 
contrast, Bacteroides remain relatively elevated throughout pregnancy [37]. Interestingly, 
microbiota compositional changes also occur post-partum. The relative abundance of 
Actinobacteria increases early post-partum, while the one of Bacteroidetes decreases [38].  
The vaginal microbiota has its own trajectory in pregnant mice. After the first week of 
pregnancy, there is an increase in bacterial diversity characterized by a growth of the Firmicutes 
and Bacteroidetes phyla [40, 41]. The changes seen in mice gut microbiota during pregnancy 
and post-partum make it a solid approach to the study of interventions in the maternal 
microbiota and the impact on offspring’s neurodevelopment.  
External Challenges to Maternal Microbiota Dynamics 
Given the importance of early-life microbiota in neurodevelopment, any factor that affects 
its composition has the potential to influence brain health. Indeed, a variety of exogenous 
factors affect the trajectory of microbiota composition during pregnancy. Diet, drugs, infection, 
hospitalization, prematurity and stress are among the influences that divert maternal microbiota 
from its natural course and impact on offspring’s brain, immune system and the hypothalamic-
pituitary-adrenal axis (HPA) development.  
Diet and Maternal Microbiota 
Diet is one of the major sculptors of the diversity and abundance of the intestinal 
microbiota [42]. Inadequate intake of macronutrients or micronutrients during pregnancy has 
been related to altered maternal microbiota [43] and offspring’s poor neurocognitive outcome 
(Table 2) [44]. This association suggests a role for the maternal microbiota in brain prenatal 
programming.  
One of the most common macronutrient consumption imbalances during pregnancy is 
the consumption of high-fat diets. Maternal overweight has been associated in humans with 
increased risk of poor neurodevelopmental outcomes [45]. In rodents, consumption of a high-fat 
or Western diet prior and during pregnancy impairs the trajectory of maternal and offspring’s 
microbiota [37, 46]. This alteration was associated with a neuroinflammatory profile in the 
hippocampus and amygdala of the offspring, resulting in juvenile impaired social behaviour and 
anxiety-like phenotype [47]. Interestingly, a high-fat diet prior to and during pregnancy impairs 
maternal HPA axis plasticity and the offspring’s hypothalamic gene response to stress [48, 49]. 
However, caution is required when interpreting the literature on the neurobiological changes 
induced by diets rich in fat and sugar in rodents as the content of the control diets regarding 
fibre and other nutrients needs to be taken into account [50, 51]. Nevertheless, preclinical 
studies on maternal high-fat and Western diets (see [8] for an extensive review) support the 
idea of a role for diet-induced microbiota changes in brain programming.  
During fetal development, micronutrients are required for neurological development. 
Deficiency in B vitamins, folate or ions, such as iron and zinc, exerts detrimental effects on 
neurocognitive development in humans and rodents [52, 53]. Folate deficiency is paradigmatic 
of the impact of micronutrient deficit on offspring neurodevelopment. Mammalian cells are 
unable to synthetize this vitamin; thus, humans depend on food or supplements to compensate 
for their requirement [54]. Failure to achieve normal serum folate levels during pregnancy has 
been associated with increased neural tube defects in the offspring [55]. Conveniently, bacteria 
residing in our colon can produce many vitamins of the B group, including folate. In mice, a loss-
of-function mutation in an intestinal folate transporter can account for folate malabsorption, 
suggesting that bacterial produced folate plays a major role in host metabolism [56]. In humans, 
consumption of a vegetarian diet during early pregnancy was associated with a distinctive 
microbial composition rich in biosynthesis pathways for fatty acids, lipids and folate [57].  
Prebiotics and Probiotics 
Research on the effect of prebiotic and probiotic administration during pregnancy is at an 
early stage (Table 3). Current reports indicate that the administration of prebiotics or probiotics 
to pregnant women is not associated with an increase or decrease in the risk of preterm birth or 
other infant and maternal adverse pregnancy outcomes [58]. Researchers are beginning to 
shed light on their effects on offspring’s brain and immune development [58].  
Prebiotics promote the growth of beneficial bacteria and include indigestible fibres that 
are fermented by colonic bacteria to produce short-chain fatty acids and provide a health benefit 
[59]. In humans, the effects of maternal intake of prebiotics on neurodevelopment have not 
been well studied, and there is uncertainty about their effects on allergy risk [60, 61]. Galacto-
oligosaccharide (GOS) and inulin administration to pregnant mice modulated the gut microbiota 
and prevented immune activation and intestinal permeability in the offspring [62]. Moreover, it 
has recently been shown that the addition of inulin to a mouse maternal high-fat diet abrogated 
the negative metabolic effect of the high-fat diet on offspring [63].  
Probiotics are beneficial strains of bacteria that confer a health benefit to the host [64]. 
There is lack of research on the prenatal impact of probiotics on neurodevelopment in humans 
and rodents. Administration of probiotics to pregnant women impact on immunity, reducing the 
risk of atopy but not of asthma [65, 66]. More preclinical and clinical research must be 




Antibiotics are widely used during pregnancy, but little is known about their effects on the 
trajectory of the maternal microbiome [67]. Preclinical models are starting to shed light on the 
effect of antibiotic exposure on offspring neurodevelopment. Administration of antibiotics to 
pregnant rats caused impairments in social behaviour and pre-pulse inhibition of the offspring 
[68]. In mice, administration of non-absorbable antibiotics during pregnancy reduced the 
exploratory behaviour in the offspring [69]. These results warrant further research on the effect 
of microbiota.  
Psychotropics 
Recently, Maier et al. [70] showed that a large amount of non-antibiotic human-targeted 
drugs have antimicrobial properties. Among them, drugs that can be prescribed during 
pregnancy, such as proton pump inhibitors, were found to disturb the growth of commensal 
bacteria (Table 2). Interestingly, psychotropic medications also influence the composition of gut 
bacteria in rodents [70, 71]. Selective serotonin uptake inhibitors, tricyclic antidepressants and 
antipsychotics negatively impact bacterial growth [71–73]. Looking at the effects on postnatal 
development, prenatal exposure to fluoxetine induces an anxiety-like phenotype in rats [74]. 
Also, in rodents, valproic acid administration during pregnancy disturbs the microbiome of the 
offspring and results in impairment of the social behaviour of the offspring [75, 76]. Owing to the 
prevalence of psychotropic administration during pregnancy, it is crucial to characterize the 
interaction between maternal health, microbiota and offspring neurodevelopment (Table 2).  
Stress and the Maternal Microbiota  
In humans, prenatal and postnatal maternal stress has been associated with young adult 
offspring behavioural and depressive symptoms [77] and aberrant infant intestinal microbiota 
development (Table 2) [78, 79]. In rodents, prenatal stress shifts maternal gut and vaginal 
bacterial community and induces long-lasting alterations in the gut microbiota composition of 
the offspring [40, 80]. Moreover, this alteration was shown to occur in a sex-specific manner, 
and it correlates with hyper-reactivity of the HPA axis [40]. 
The Microbiota in Transition: from Prenatal to Postnatal  
When the first contact with the microbiota occurs remains controversial. The sterility of 
the uterus during pregnancy is one of the paradigms that research on the microbiome is 
revisiting. Bacteria have been found in the placenta [81, 82], amniotic fluid and meconium of 
humans [83, 84]. Moreover, the presence of specific bacteria in utero has been associated with 
pregnancy risks, including higher rates of preterm delivery [85]. Nevertheless, the reliability of 
these findings is widely debated in the context of whether it is contamination or not [86, 87]. The 
existence of germ-free mice models further dismisses the idea of a prenatal microbiome [86]. It 
is generally accepted that the moment of birth is the first opportunity for large-scale bacterial 
colonization of the newborn. Thus, the mode of delivery has a tremendous impact on the 
establishment of the microbiota of infants. 
Early-Life Microbiota and Birth Mode 
A large number of studies associate the mode of delivery to a distinctive trajectory of 
microbiota development in the newborn [35, 36, 66, 88–99]. Unexposed to the birth canal, 
Caesarean section (C-section)-born babies elude mother-neonate vertical vaginal transmission 
of bacteria and viruses [36, 89, 100]. In turn, the microbiota resembles skin and environment 
microbiota, suggesting that C-section first colonizers come from diverse sources (Table 2) [35, 
89].  
That said it is worth reinforcing that mode of delivery-induced changes in microbiota 
composition are transitory. Vaginally delivered infants have significantly higher microbiota 
richness and diversity than C-section-born infants as early as 3 days after birth [88, 100–102]. 
Nevertheless, the early decline in Proteobacteria and the late Firmicutes expansion occur timely 
over the first year of life of C-section-born infants [101]. 
The time course of these microbiota alterations overlaps with a critical period for neuro- 
and immune development (see [103] for extensive review). It has been suggested that C-
section-distinctive microbiota composition plays a functional role in predisposing these infants to 
a greater relative risk of neonatal infections, allergy, asthma, obesity and type 1 diabetes [35, 
101, 104–108]. Preclinical models of C-section suggest that the mode of delivery could impact 
on early neuronal maturation [109, 110]. Whether modifying the initial colonizing microbiota 
induces directly or indirectly different trajectories in brain development has yet to be deciphered. 
Epidemiology studies have shown that C-section-induced changes in terms of brain 
health and school performance later in life are subtle at best [111, 112] and, in the case of 
autism, do not withstand correcting for familial confounding [111]. 
Various strategies have been designed to restore the normal trajectory of the microbiota 
[113]. Although controversial, artificial vaginal microbiota transference was performed to C-
section-born infants to mimic vertical transmission [114]. Other interventions, including 
supplementation with probiotics and prebiotics, were proposed to decrease the impact of 
delivery mode on the microbiota.  
Early Postnatal Perturbations of the Microbiota 
Early postnatal life entails an intrinsic sensitivity to environmental factors. As with the 
maternal microbiome, infant exposure to differences in diet, drugs and stress can interfere with 
the trajectory of the microbiota and neurodevelopment in a manner that is characteristic of this 
developmental period.  
Mode of Nutritional Provision in Early Life 
The stability and composition of the early-life gut microbiota community is also dependent 
on diet [115]. Accumulating evidence suggests that breastfeeding and formula-based nutrition 
leave a distinctive fingerprint in the intestinal microbiota (Table 2). Gut bacterial composition of 
infants exclusively breastfed is characterized by higher relative abundance of Bacteroides and 
Bifidobacterium compared to the one from formula-fed infants [108, 116]. Furthermore, 
breastfeeding had a positive effect on myelination and increased general, verbal and non-verbal 
cognitive abilities during childhood [117]. The implications of these findings are still unclear, but 
longitudinal studies are starting to shed light on the effect of early-life nutrition on the temporal 
course of microbiota maturation.  
Human breast milk has a unique composition that interacts with the developing gut 
microbiota. Culture-dependent and -independent techniques revealed that it is a source of 
bacteria [118]. Interestingly, the human milk microbiome can be influenced by maternal body 
mass index and mode of delivery [119]. The other main components of breast milk are human 
milk oligosaccharides, which act as prebiotics [120, 121]. Supplementation of infant formula with 
GOS increases the abundance of Bifidobacteria and Lactobacilli to levels reported in breastfed 
infants [122, 123]. Both breast milk microbes and prebiotics play a role in the standard gut 
microbial developmental trajectory.  
Later in life, feeding transitions drive important changes in composition and functionality 
of the intestinal microbiota [36, 89, 124]. From breastfeeding to solid food, the microbiome 
transitions from being enriched in genes associated with digestion of sugars from breast milk, 
vitamin production and iron transport to degradation of starch and high sugars [36]. 
Furthermore, the microbiota continues to undergo change; at 7–12 years of age, the 
composition and function of the microbiota remains significantly different from the one of adults 
[125], suggesting a role of the microbiome in the neurodevelopmental changes associated with 
adolescence.  
Probiotics and Prebiotics 
Most of the evidence available on the effect of early-life exposure to pre- and probiotics 
comes from preclinical studies. Early-life prebiotic administration in humans has shown effects 
on reducing the risk of atopy, an autoimmune disease [126], but neurodevelopmental outcomes 
have not been studied yet. In preclinical studies, oligosaccharides have been shown to 
modulate the gut-brain axis, highlighting the role of breastfeeding in neurodevelopment. 
Administration of the human milk oligosaccharides 3’Sialyllactose (3’SL) or 6’Sialyllactose (6’SL) 
to mice exposed to social disruption prevented stress-induced colonic microbial disruption and 
anxiety-like behavior [127]. Furthermore, fructo-oligosaccharide (FOS) and GOS administration 
attenuated corticosterone release in response to an acute stressor and protected the mice from 
the impact of chronic stress on the microbiota [128].  
Preliminary clinical trials of probiotic interventions have yielded promising results with 
regard to reducing the risk for gastrointestinal problems, sepsis, allergies and even autism 
spectrum disorder and attention deficit hyperactivity disorder [129–134]. Several groups have 
now shown that early probiotic interventions mitigate the effects of early-life stress, maternal 
high-fat diet and maternal immune activation on infant outcomes [47, 135–138]. Oral 
administration at weaning of Bifidobacterium fragilis ameliorates the abnormal stereotyped and 
anxiety-like behaviours of the maternal immune activation mouse model of autism [136]. 
Probiotic administration during adolescence restores social interaction-induced long-term 
potentiation in an animal model of social impairment by maternal high-fat diet exposure [47]. In 
maternally separated rat pups, a combination of Lactobacillus rhamnosus and Lactobacillus 
helveticus reduced pup corticosterone responses to stress and normalized fear behaviour [135, 
137, 138]. Another probiotic, Bifidobacterium infantis, normalized behavioural deficits in adult 
rats exposed to maternal separation [139].  
Although clinical evidence on the role of pre- and probiotics for neurodevelopment is still 
lacking, preclinical research gives cause for a focus on early-life microbiota interventions.  
Drugs: Antibiotics and Beyond in a Paediatric Setting 
Antibiotics are commonly prescribed during the first years of life, yet the effect on brain 
health programming is unknown. Longitudinal clinical studies support the idea that early-life 
exposure to antibiotics perturbs the natural trajectory of the microbial communities by altering 
their stability [140]. Furthermore, neonatal exposure to antibiotics in rodents not only altered the 
microbiota but also induced increased visceral sensitivity and long-lasting changes in brain 
cytokines and behaviour [141, 142].  
The interaction between early-life exposure to psychotropics, neurodevelopment and the 
microbiota is currently unknown. Not only exposure to psychotropics mediated by breastfeeding 
but direct administration of these drugs early in life could impact the developing microbiota. 
Serotonin uptake inhibitors and atypical antipsychotics indicated for the treatment of paediatric 
psychiatric disorders are among the non-antibiotic drugs known to change the microbiome 
composition [70, 71]. Atypical antipsychotics indicated for the treatment of the irritability 
associated with autism spectrum disorders have been shown to inhibit gut bacteria [70]. At the 
same time, the composition of the microbiota of autistic patients was shown to be altered [143–
147]. Whether there is an interaction between microbiota populations, psychotropic drugs and 
behaviour has yet to be determined.  
Early-Life Stress 
The impact of stress on the development of the HPA axis has been shown to contribute to 
the programming of brain health in later life [148]. Interestingly, evidence from preclinical studies 
shows that early-life stress also alters the microbiota. Maternal separation during early life 
disrupted the microbiota of the offspring of rhesus monkeys and rats [149, 150]. Interestingly, a 
diet containing prebiotics in combination with live Lactobacillus rhamnosus GG attenuated the 
effects of early-life maternal separation on anxiety-like behaviour and hippocampal-dependent 
learning [151]. Germ-free mice were more vulnerable to restraint stress, resulting in higher 
adrenocorticotropic hormone and corticosterone in plasma [14, 16], a reduction in glucocorticoid 
receptor mRNA and an increased stress response [14]. Remarkably, these effects were rescued 
with microbiota transplantation during adolescence but not adulthood [14]. 
Future Perspectives 
Pregnancy and the first years of life are unique stages of plasticity for the intestinal 
microbiota. In both cases, there is a dynamic trajectory of the intestinal microbiota composition 
that is functional to the requirements of the host. Although plasticity represents an opportunity 
for adaptation, it is also a vulnerable stage. As we have reviewed, clinical and preclinical studies 
suggest that diet, stress and drugs can interact with the natural trajectory of the microbiota and 
play a part in programming brain health (Fig. 1). However, the evidence is still scarce, and 
further research is needed to understand the functional implications of these interactions.  
The nervous system and the microbiota show concurrent developmental trajectories, 
offering a unique opportunity for intervention. There is potential for the development of early-life-
targeted interventions of the microbiome, aiming to reduce the risk of disease later in life. 
Further research is needed on the characterization of critical windows to modulate the 
microbiota and the consequences of early intervention.  
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Fig. 1. Factors that determine the trajectory of the microbiota during early life. The gut and 
vaginal microbiome of the mother is altered by diet, drugs and stress. The mode of 
delivery determines the first colonizers of the newborn’s gut. Early in life, diet, drugs and 
stress can also affect the infant microbiota composition.  
Table(s) 
 






Gut-brain axis The multidirectional biological system comprising the central nervous 
system, the neuroendocrine and neuroimmune systems, the 




Microbiota The collection of microbes (including bacteria, viruses and fungi) that 
inhabit a particular site 
  
  
Microbiome The totality of the microbial genes at a particular site 
  
  
Host The organism that houses a given microbial population 
  
  
Commensal microorganisms The intrinsic microbes that reside in the host 
  
  
Prebiotic Non-digestible foods that have a beneficial effect on the microbiome 
for the host 
  
  
Probiotic Live microbes that have a positive effect on host health when 
ingested in adequate quantities 
  
  
Germ free A host without a microbiome; generally refers to mice and rats that 
were born and reared in a sterile environment to keep them from 






Table 2. Factors that interfere with the gut microbiota trajectory during development 
    
    
Factor  Effect on the microbiota Ref. 
    
    
Diet pregnancy Unhealthy diets can disrupt the 
natural trajectory of microbiota during 
pregnancy 
[31] 
early life Formula feeding is associated with a 




    
    
Mode of delivery C-section is associated with a 
distinctive early microbial profile, 
dissimilar to the vaginal microbiota 
implicated in vertical transmission 
[35]  
    
    
Drugs non-antibiotic Inhibition of commensal bacteria 





antibiotic Reduce the stability of early-life 
microbiota 
    
    
Stress Prenatal and postnatal stress alter 
the composition of early-life 
microbiota 
[78]  
    




Table 3. Interventions that support microbiota development 
    
    
Factor Effect on the microbiota Ref.  
    
    
Diet pregnancy Diets high in fibre improve gut 
microbiota diversity 
[152] 
early life Due to its unique composition that 
includes prebiotics, breast milk 
supports early-life microbial 
development 
[108] 
    
    
Prebiotic Growth stimulation of specific bacteria 
populations that is associated 
with a health benefit 
[153]  
    
    
Probiotic Modulates microbiota functionality, 
intestinal immunity and  
epithelial responsiveness 
In adequate amounts confers health 
benefits to the host 
[154]  
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